Author:
Olafsson Sigurdur,Fridriksdottir Ragnheidur H,Love Thorvardur J,Tyrfingsson Thorarinn,Runarsdottir Valgerdur,Hansdottir Ingunn,Bergmann Ottar M,Björnsson Einar S,Johannsson Birgir,Sigurdardottir Bryndis,Löve Arthur,Baldvinsdottir Gudrun E,Hernandez Ubaldo Benitez,Gudnason Thorolfur,Heimisdottir Maria,Hellard Margaret,Gottfredsson Magnus
Subject
Gastroenterology,Hepatology
Reference31 articles.
1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017
2. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection;Feld;N Engl J Med,2015
3. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews;Nelson;Lancet,2011
4. Eradication of hepatitis C infection: the importance of targeting people who inject drugs;Hellard;Hepatology,2014
5. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial;Grebely;Lancet Gastroenterol Hepatol,2018
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献